Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Betamethasone 17-benzoate
1. Betamethasone 17-benzoate
2. 22298-29-9
3. Uticort
4. Benisone
5. W 5975
6. W-5975
7. Ms 1112
8. 877k0xw47a
9. Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-, (11.beta.,16.beta.)-
10. Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16beta)-
11. 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-benzoate
12. Euvaderm
13. Flurobate
14. Parbetan
15. Beben
16. Unii-877k0xw47a
17. Betamethasone Benzoate [usan:usp]
18. Einecs 244-897-9
19. Uticort (tn)
20. Betamethasone-17-benzoate
21. Bethamethasone 17-benzoate
22. Schembl49469
23. [(8s,9r,10s,11s,13s,14s,16s,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] Benzoate
24. Betamethasone Benzoate (usp)
25. Chembl1200376
26. Dtxsid2022670
27. Chebi:135798
28. Zinc4212134
29. Betamethasone Benzoate [usan]
30. Betamethasonebenzoate(200mg)
31. Hy-u00161
32. Betamethasone Benzoate [vandf]
33. Betamethasone Benzoate [mart.]
34. Betamethasone Benzoate [usp-rs]
35. Betamethasone Benzoate [who-dd]
36. Cs-7216
37. 9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-benzoate
38. Betamethasone 17-benzoate [mi]
39. Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methyl-, 17-benzoate
40. Betamethasone Benzoate [orange Book]
41. Betamethasone Benzoate [usp Impurity]
42. D02286
43. Q27269802
44. (11.beta.,16.beta.)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione17-benzoate
45. (11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl Benzoate
46. 9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl Benzoate, (11.beta.,16.beta.)-#
Molecular Weight | 496.6 g/mol |
---|---|
Molecular Formula | C29H33FO6 |
XLogP3 | 3.9 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 496.22611693 g/mol |
Monoisotopic Mass | 496.22611693 g/mol |
Topological Polar Surface Area | 101 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 1030 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?